HemoSonics : Welcomes FDA Support of Viscoelastic Coagulation Analyzers for COVID-19 Patients; Highlights the Benefits of the Quantra® Hemostasis Analyzer
HemoSonics welcomes the January 14th guidance of the US Food and Drug Administration that broadens the use of viscoelastic coagulation analyzers for hospital patient healthcare settings in response...
Source: marketscreener.com